In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates
The DOI matches its Crossref record; 66 of the 72 references it cites were found in a registry or an index.
Abstract
The central type benzodiazepine receptor (BDZr), an allosteric modulatory site of the GABAA receptor-anion channel, has been shown in vitro to respond to drugs with positive efficacy (agonists), zero efficacy (competitive antagonists) and drugs with negative efficacy (inverse agonists). However, this general concept of the function of BDZr drugs has rarely been assessed in intact living brain. We report here in on a non-invasive in vivo assessment of the intrinsic efficacies of BDZr drugs in the brain of non-human primates. We have performed an in vivo simultaneous determination of fractional BDZr occupancy and the resulting pharmacological efficacies of the full agonist diazepam, the partial agonist bretazenil, the antagonist flumazenil (Ro15-1788), the partial inverse agonist Ro15-4513 and the full inverse agonist methyl beta-carboline-3-carboxylate (beta-CCM). Positron emission tomography (PET) was used to estimate fractional BDZr occupancy measured as the in vivo displacement in the brain of the positron emitter radioligand, [11C]flumazenil. Simultaneously, the proconvulsant or anticonvulsant efficacies of the BDZr drugs were measured as their abilities to facilitate or counteract the central effects of an infusion of pentylenetetrazol, a non-competitive GABA antagonist acting on the picrotoxin site of the receptor complex. This was measured using electroencephalographic recording (EEG). Our results show that, in vivo, the fractional receptor occupancy by a given drug is perfectly correlated with its resulting graded pharmacological effects, as predicted from the competitive drug receptor interaction theory. Furthermore, the slope of the relationship between fractional receptor occupancies and the resulting pharmacological effects (an index of intrinsic efficacy) strictly depends on the BDZr ligand considered. Diazepam displayed a strong positive intrinsic efficacy, and, in contrast, beta-CCM a marked negative one. Between these two extremes, the partially active drugs bretazenil and Ro15-4513, which required a large fractional receptor occupancy to produce significant anti- or proconvulsant effects, respectively, displayed only a weak intrinsic efficacy. Flumazenil did not produce any significant pharmacological effect. We observed that the in vivo intrinsic efficacies of diazepam, flumazenil and beta-CCM correlate with their intrinsic efficacies as measured by their modulatory effects on the GABA-dependent membrane chloride conductance in vitro. Thus, the intrinsic efficacies measured using PET and EEG are likely to reflect the different in vivo abilities of BDZr drugs to induce or stabilize the GABAA-benzodiazepine chloride channel in a given conformation.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, decreasing medication by constant amounts (linear tapering) tends to cause increasingly severe side effects 47,50,51 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [51]
In the citing paper
“Withdrawal regimes for benzodiazepines recommend dosage reductions that are proportional to the current dose (most commonly suggesting 10% reductions), yielding exponentially decreasing regimes, as opposed to linear reductions 47,51,53 (Figure 2b).”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [51]
In the citing paper
“The shape of the relationship between dose of benzodiazepine and activity at gamma-aminobutyric acid-A (GABA-A) receptors is hyperbolic: steeply inclining at low doses, flattening at higher doses.”
From Pharmacological principles for safe benzodiazepine and Z-drug dose reduction (2026) · cites this paper as Brouillet et al., 1991
In the citing paper
“This table, based on the E max equation of best fit derived from the data in Brouillet et al. (1991), after conversion to human equivalent dosage (Nair & Jacob, 2016), allows transformation from dosage of diazepam to indicator of biological effect, based on percentage occupancy of GABA-A”
From Pharmacological principles for safe benzodiazepine and Z-drug dose reduction (2026) · cites this paper as Brouillet et al., 1991
In the citing paper
“PET scanning, using the radioligand [11C]flumazenil in non-human primates (Figure 2a), allows visualization of this hyperbolic relationship (Atkins & Nimmo, 1975; Brouillet et al., 1991; Holford, 2018).”
From Pharmacological principles for safe benzodiazepine and Z-drug dose reduction (2026) · cites this paper as Brouillet et al., 1991
Citations
Cites
Benzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,700
Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding
Braestrup, C., & Squires, R. F. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3805 · Cited by 1,264
Selective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
Farde, L., Hall, H., Ehrin, E., & Sedvall, G. (1986) · Science · doi:10.1126/science.2867601 · Cited by 831
Type I and Type II GABA A -Benzodiazepine Receptors Produced in Transfected Cells
Pritchett, D. B., Lüddens, H., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2551039 · Cited by 717
Structural and functional basis for GABAA receptor heterogeneity
Levitan, E. S., Schofield, P. R., Burt, D. R., Rhee, L. M., Wisden, W., Köhler, M., Fujita, N., Rodriguez, H. F., Stephenson, A., Darlison, M. G., et al. (1988) · Nature · doi:10.1038/335076a0 · Cited by 589
Squires, R. F., Casida, J. E., Richardson, M., & Saederup, E. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14273-9 · Cited by 551
Interaction of Convulsive Ligands with Benzodiazepine Receptors
Braestrup, C., Schmiechen, R., Neef, G., Nielsen, M., & Petersen, E. N. (1982) · Science · doi:10.1126/science.6281892 · Cited by 547
A Selective Imidazobenzodiazepine Antagonist of Ethanol in the Rat
Suzdak, P. D., Glowa, J. R., Crawley, J. N., Schwartz, R. D., Skolnick, P., & Paul, S. M. (1986) · Science · doi:10.1126/science.3022383 · Cited by 543
Cerebellar GABAA receptor selective for a behavioural alcohol antagonist
Lüddens, H., Pritchett, D. B., Köhler, M., Killisch, I., Keinänen, K., Monyer, H., Sprengel, R., & Seeburg, P. H. (1990) · Nature · doi:10.1038/346648a0 · Cited by 538
High densities of benzodiazepine receptors in human cortical areas
BRAESTRUP, C., ALBRECHTSEN, R., & SQUIRES, R. F. (1977) · Nature · doi:10.1038/269702a0 · Cited by 414
Benzodiazepine/GABA Receptors and Chloride Channels: Structural and Functional Properties.
Jenner, P. G. (1987) · Journal of Neurology Neurosurgery & Psychiatry · Cited by 371
IN-VIVO DEMONSTRATION OF REDUCED BENZODIAZEPINE RECEPTOR BINDING IN HUMAN EPILEPTIC FOCI
Savic, I., Roland, P., Sedvall, G., Persson, A., Pauli, S., & Widen, L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92468-3 · Cited by 367
Polc, P., Bonetti, E. P., Schaffner, R., & Haefely, W. (1982) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00498510 · Cited by 314
Ramanjaneyulu, R., & Ticku, M. K. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90282-6 · Cited by 294
MACDONALD, R. L., & BARKER, J. L. (1977) · Nature · doi:10.1038/267720a0 · Cited by 259
IMPORTANT CONCEPTS OF RECEPTOR THEORY
RUFFOLO, R. R. (1982) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1982.tb00520.x · Cited by 258
Brain Specific Benzodiazepine Receptors
Bræstrup, C., & Squires, R. F. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.3.249 · Cited by 202
Maziere, M., Hantraye, P., Prenant, C., Sastre, J., & Comar, D. (1984) · The International Journal of Applied Radiation and Isotopes · doi:10.1016/0020-708x(84)90215-1 · Cited by 187
Self-citationPersson, A., Ehrin, E., Eriksson, L., Farde, L., Hedström, C.-G., Litton, J.-E., Mindus, P., & Sedvall, G. (1985) · Journal of Psychiatric Research · doi:10.1016/0022-3956(85)90080-9 · Cited by 174
Samson, Y., Hantraye, P., Baron, J. C., Soussaline, F., Comar, D., & Mazière, M. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90218-3 · Cited by 170
Self-citationTicku, M. K., & Maksay, G. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90630-6 · Cited by 165
Ligands for benzodiazepine receptors with positive and negative efficacy
Bræstrup, C., Honoré, T., Nielsen, M., Petersen, E. N., & Jensen, L. H. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90438-6 · Cited by 157
Benzodiazepine receptors: labeling in intact animals with [3H] flunitrazepam
Chang, R. S. L., & Snyder, S. H. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90330-8 · Cited by 154
The Benzodiazepine Receptor in Normal and Pathological Human Brain
Möhler, H., & Okada, T. (1978) · The British Journal of Psychiatry · doi:10.1192/bjp.133.3.261 · Cited by 151
Chloride channels and their modulation by neurotransmitters and drugs.
Biggio, G., & Costa, E. (1988) · PubMed · Cited by 136
Correlation between benzodiazepine receptor occupation and anticonvulsant effects of diazepam
Paul, S. M., Syapin, P. J., Paugh, B., Moncada, V. Y., & Skolnick, P. (1979) · Nature · doi:10.1038/281688a0 · Cited by 127
GABA reduces binding of 3H-methyl β-carboline-3-carboxylate to brain benzodiazepine receptors
Bræstrup, C., & Nielsen, M. (1981) · Nature · doi:10.1038/294472a0 · Cited by 123
Pappatà, S., Samson, Y., Chavoix, C., Prenant, C., Mazière, M., & Baron, J. (1988) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1988.65 · Cited by 122
Self-citationChan, C., & Farb, D. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-09-02365.1985 · Cited by 122
Visualisation of 11C-flunitrazepam displacement in the brain of the live baboon
Comar, D., Mazière, M., Godot, J. M., Berger, G., Soussaline, F. P., Menini, C., Arfel, G., & Naquet, R. (1979) · Nature · doi:10.1038/280329a0 · Cited by 106
Self-citationBlin, J., Sette, G., Fiorelli, M., Bletry, O., Elghozi, J. L., Crouzel, C., & Baron, J. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01229.x · Cited by 106
Ro 15-4513: Partial inverse agonism at the BZR and interaction with ethanol
Bonetti, E. P., Burkard, W. P., Gabl, M., Hunkeler, W., Lorez, H., Martin, J. R., Möhler, H., Osterrieder, W., Pieri, L., Polc, P., et al. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90259-6 · Cited by 93
Miller, L. G., Greenblatt, D. J., Paul, S. M., & Shader, R. I. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22587-3 · Cited by 91
Hantraye, P., Kaijima, M., Prenant, C., Guibert, B., Sastre, J., Crouzel, M., Naquet, R., Comar, D., & Mazière, M. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90005-3 · Cited by 91
Self-citationRo 16-6028: A Novel Anxiolytic Acting as a Partial Agonist at the Benzodiazepine Receptor
Martin, J., Pieri, L., Bonetti, E., Schaffner, R., Burkard, W., Cumin, R., & Haefely, W. (1988) · Pharmacopsychiatry · doi:10.1055/s-2007-1021947 · Cited by 90
Visualization of specific binding sites of benzodiazepine in human brain.
Shinotoh, H., Yamasaki, T., Inoue, O., Itoh, T., Suzuki, K., Hashimoto, K., Tateno, Y., & Ikehira, H. (1986) · PubMed · Cited by 88
Persson, A., Pauli, S., Halldin, C., Stone‐Elander, S., Farde, L., Sjögren, I., & Sedvall, G. (1989) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.470040105 · Cited by 85
In vivo receptor occupation by benzodiazepines and correlation with the pharmacological effect
Duka, T., Höllt, V., & Herz, A. (1979) · Brain Research · doi:10.1016/0006-8993(79)90498-0 · Cited by 80
Benzodiazepine receptor binding with [3H]-Ro 15-1788
Goeders, N. E., & Kuhar, M. J. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90505-3 · Cited by 77
RICHE, D., Hantraye, P., Guibert, B., Naquet, R., Loc’h, C., Maziere, B., & Mazière, M. (1988) · Brain Research Bulletin · doi:10.1016/0361-9230(88)90058-5 · Cited by 74
Self-citationDemonstration of [3H] diazepam binding to benzodiazepine receptors
Williamson, M. J., Paul, S. M., & Skolnick, P. (1978) · Life Sciences · doi:10.1016/0024-3205(78)90560-x · Cited by 56
Benzodiazepine receptors': Correlation with pharmacological responses in living animals
Mennini, T., & Garattini, S. K. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90094-7 · Cited by 53
Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomography
Shinotoh, H., Iyo, M., Yamada, T., Inoue, O., Suzuki, K., Itoh, T., Fukuda, H., Yamasaki, T., Tateno, Y., & Hirayama, K. (1989) · Psychopharmacology · doi:10.1007/bf00442808 · Cited by 52
Cepeda, C., Tanaka, T., Besselièvre, R., Potìer, P., Naquet, R., & Rossier, J. (1981) · Neuroscience Letters · doi:10.1016/0304-3940(81)90358-x · Cited by 48
Haigh, J. R. M., & Feely, M. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90788-1 · Cited by 48
Mehta, A. K., & Ticku, M. K. (1989) · Brain Research · doi:10.1016/0006-8993(89)90011-5 · Cited by 45
Seizures in Drug-Treated Animals
Miczek, K. A., & Weerts, E. M. (1987) · Science · doi:10.1126/science.235.4793.1127a · Cited by 40
Partial agonists of the benzodiazepine receptor: from animal data to results in patients.
Haefely, W. E. (1988) · PubMed · Cited by 37
Corda, M. G., Giorgi, O., Longoni, B., & Biggio, G. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90153-2 · Cited by 35
Hantraye, P., Chavoix, C., Guibert, B., Fukuda, H., Brouillet, E., Dodd, R. H., Prenant, C., Crouzel, M., Naquet, R., & Mazière, M. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90438-9 · Cited by 34
Self-citationDemonstration of the partial agonist profiles of Ro 16-6028 and Ro 17-1812 in mice in vivo
Potier, M., de Carvalho, L. P., Venault, P., Chapouthier, G., & Rossier, J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90161-6 · Cited by 34
Mennini, T., Cotecchia, S., Caccia, S., & Garattini, S. K. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90409-9 · Cited by 27
Hantraye, P., Brouillet, E., Fukuda, H., Chavoix, C., Guibert, B., Dodd, R. H., Prenant, C., Crouzel, M., Naquet, R., & Mazière, M. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90584-5 · Cited by 22
Self-citationBrouillet, E., Chavoix, C., Khalili-Varasteh, M., Bottlaender, M., Hantraye, P., Yorke, J. C., & Mazière, M. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09469-6 · Cited by 21
Self-citationPentylenetetrazol-induced seizure is not mediated by benzodiazepine receptors in vivo
Hantraye, P., Brouillet, E., Guibert, B., Chavoix, C., Fukuda, H., Prenant, C., Crouzel, M., Naquet, R., & Mazière, M. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90171-7 · Cited by 20
Self-citationChweh, A. Y., Swinyard, E. A., Wolf, H. H., & Kupferberg, H. J. (1983) · Epilepsia · doi:10.1111/j.1528-1157.1983.tb04629.x · Cited by 20
Potier, M., de Carvalho, L. P., Dodd, R. H., Besselièvre, R., & Rossier, J. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09352-6 · Cited by 19
Self-citationPieri, L., Hunkeler, W., Jauch, R., Merz, W. A., Roncari, G., & Timm, U. (1988) · Drugs of the Future · doi:10.1358/dof.1988.013.08.63039 · Cited by 19
MINCHIN, M. C. W., & Nutt, D. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00856.x · Cited by 17
In vivo labeling of central benzodiazepine receptors with the partial inverse agonist [3H]Ro 15-4513
Sadzot, B., Frost, J. J., & Wagner, H. N. (1989) · Brain Research · doi:10.1016/0006-8993(89)90094-2 · Cited by 16
Sayette, V. D. L., Chavoix, C., Brouillet, E., Hantraye, P., Kunimoto, M., Khalili-Varasteh, M., Guibert, B., Prenant, C., & Mazière, M. (1991) · Experimental Brain Research · doi:10.1007/bf00231164 · Cited by 15
Self-citationChavoix, C., Brouillet, E., Kunimoto, M., Sayette, V. D. L., Khalili-Varasteh, M., Hantraye, P., Dodd, R. H., Guibert, B., Prenant, C., Naquet, R., et al. (1991) · Epilepsy Research · doi:10.1016/0920-1211(91)90030-j · Cited by 13
Self-citationInteraction of suriclone with central type benzodiazepine receptors in living baboons
Brouillet, E., Chavoix, C., Hantraye, P., Kunimoto, M., Khalili-Varasteh, M., Chevalier, P., Frydman, A. M., Gaillot, J., Prenant, C., Crouzel, M., et al. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90151-u · Cited by 10
Self-citationIn vivo [3H]flunitrazepam binding: imaging of receptor regulation.
Ciliax, B. J., Penney, J. B., & Young, A. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24930-8 · Cited by 7
Brouillet, E., Chavoix, C., Sayette, V. D. L., Hantraye, P., Kunimoto, M., Khalili-Varasteh, M., Guibert, B., Fournier, D., Dodd, R. H., Naquet, R., et al. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90029-4 · Cited by 6
Self-citation
Research works printed but not linked: 5
- Bonnetti, 1985, The partial inverse benzodiazepine agonist Ro15-4513 antagonizes acute ethanol effects in mice and rats, Br. J. Pharmacol., 86, 463P
- Frey, 1988, Muscarinic receptors imaging in human brain using [11C]scopolamine and positron emission tomography, J. Nucl. Med., 29, 808
- Furchgott, 1966, The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes, Adv. Drug. Res., 3, 21
- Haefely, 1985, Recent advances in molecular pharmacology of benzodiazepine receptors and in the structure-activity relationships of their agonists and antagonists, Vol. 14, 165
- Mazière, 1983, 11C-Ro15-1788 et11C-Flunitrazepam, deux coordinats pour l'etude par tomographie par positons des sites de liaison des benzodiazepines, C.R. Acad. Sci., 296, 871
Cited by
Tapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280
Pike, V. W., Halldin, C., Crouzel, C., Barré, L., Nutt, D., Osman, S., Shah, F., Turton, D. R., & Waters, S. L. (1993) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(93)90082-6 · Cited by 139
Target site occupancy: Emerging generalizations from clinical and preclinical studies
Grimwood, S., & Hartig, P. R. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.002 · Cited by 139
Yanai, K., Ryu, J. H., Watanabe, T., Iwata, R., Ido, T., Sawai, Y., Ito, K., & Itoh, M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16386.x · Cited by 110
Criswell, H. E., & Breese, G. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300750 · Cited by 118
Metadata
- Authors
- Brouillet, E., Chavoix, C., Bottlaender, M., Khalili-Varasteh, M., Hantraye, P., Fournier, D., Dodd, R. H., & Mazière, M.
- Corresponding author
- Mazière, Mariannick
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 1991-08
- Volume
- 557
- Issue
- 1-2
- Pages
- 167-176
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2051214011
- Cited by
- 37
- References
- 72
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2021: 1 · 2019: 1 · 2014: 1
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondation de l'Avenir pour la Recherche Médicale Appliquée
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- benzodiazepine receptor, GABAergic neurotransmission, GABAA receptor, inverse agonists, partial agonists, intrinsic efficacy, receptor occupancy, diazepam, flumazenil, Ro 15-4513, bretazenil, pentylenetetrazole, anticonvulsant activity, proconvulsant effects, non-human primates, 11C-flumazenil PET, EEG, allosteric modulation, benzodiazepine antagonists, benzodiazepine receptor agonists
- MeSH terms
- Animals, Azides, Benzodiazepines, Benzodiazepinones, Binding, Competitive, Carbolines, Cerebral Cortex, Diazepam, Electroencephalography, Flumazenil, gamma-Aminobutyric Acid, Ligands, Male, Synaptic Transmission, Papio, Pentylenetetrazole, Receptors, GABA-A, Seizures, Tomography, Emission-Computed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.